Back to Dashboard
26

LMRI

๐Ÿฅ Healthcare

Lumexa Imaging Holdings, Inc. Common Stock

Conservative #1153Aggressive #550Moderate Risk
$14.14-2.01%
Day High$14.58
Day Low$13.85
Volume0.3M
Mkt Cap$1.3B
52W Low $1052W High $19
Market Cap
$1.4B
P/E Ratio
N/A
Rev Growth
1.4%
Sector avg: 161.5%
Earnings Growth
23.0%
Profit Margin
-9.9%
Sector avg: -3292.7%
Debt/Equity
8.10

Why This Score

LMRI scores 27.1 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.

Strengths
  • High conviction (89/100) โ€” fundamental and ML signals agree on this stock.
Risk Factors
  • Above-average volatility (20.0%) may not suit conservative risk tolerance.
  • Elevated leverage (D/E 8.10) increases financial risk in a rising-rate environment.

Minor adjustments (-2.0 points) applied. LMRI's rank of #1153 primarily reflects its factor profile relative to the conservative weight vector.

Score Breakdown

Overall Score27.1
Fundamental Score22.1
ML Score36.0

Score by Horizon

3 Month
57.5
6 Month
64.3
Primary
1 Year
67.7

Quality Assessment

F
Quality Grade
Low quality โ€” significant fundamental weaknesses
1 quality flag detected โ€” see details below. These penalties are already factored into the final score.
Quality Flags
Extreme leverage: D/E ratio of 8.1x โ€” balance sheet risk

Position Sizing

Suggested Allocation
4%
Confidence
medium

Score Composition Waterfall

How each component affects the final score
Backtested Scoring Levers (IC-calibrated from 30y ElasticNet)
Weinstein (12.1%)
50
Basing
Sentiment (2.5%)
78
Positive
Analyst (6.4%)
100
Favorable
Tradability (post-hoc)
80
Grade A
Base
24.9
SHAP
-1.0
Factors
+0.9
Conviction
+2.3
Final
27.1
Positive adjustment
Negative adjustment
Base blend
Final score

Factor Breakdown

41AVG
Value50
Quality11
Growth59
Stability40
Investment45

Signal SegmentsComputed from ML features

Fundamental (Valuation, Quality, Growth)42.0
Technical (Momentum, Weinstein, Volatility)52.0
External (Sentiment, Analyst, Macro)94.0
Scores below 50 indicate weakness in that segment relative to the universe.

Data Quality

Score
Features
Confidence
Feature Coverage72%

Growth Estimates

Short-term
-1.2% to +3.0%
Medium-term
-1.3% to +5.0%
Long-term
-1.3% to +7.1%

ML Model Core Features100 trained inputs โ†’ ML Score: 36

These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.

Analyst Intelligence
Consensus Score100.0/100
Target Upside+50.0%
Coverage1 analysts
Market Sentiment
Sentiment Score77.5/100
News Volume1 articles
Technical Stage
Weinstein Stage1 โ€” Basing
Volatility+0.2%
Momentum & Technical
Momentum Acceleration+0.0%
Momentum ConsistencyDivergent (0.00)
Relative Strength vs Sector-24.4%
Trend Strength (ADX Proxy)Weak (0.0)
Momentum Quality+0.000
Momentum BreadthNarrow
Macro Regime
Bull RegimeYes
High Vol RegimeNo
S&P 500 Return+25.0%
Yield Curve-0.1bp

Sector-Relative AnalysisIn-model features

Value Trap Signal
8%
Low risk
Sector RevGr Rank
P44
Revenue growth vs Healthcare peers
Sector PE Rank
P22
Valuation vs Healthcare peers
Sector FCF Rank
P63
Free cash flow vs Healthcare peers
Growth Deviation
-0.0ฯƒ
Z-score vs sector median
Stagnation Flag
NO
Not flagged

Analysis Signals

Scoring Factors
Fundamental score of 22 relative to sector peers22/100
Machine learning ensemble ranks this stock at the 36th percentileP36
Blended score: 80% fundamental (22) + 20% ML (36) = 24.924.9
Risk assessment: low. Low vol 0.2%Low
Earnings quality grade F: quality flags triggered โ€” see details below. Score adjusted by 0 pointsGrade F
Conviction adj: +2.3pt (conviction=N/A)Conviction
Risk Factors
Quality concern: Extreme leverage: D/E ratio of 8.1x โ€” balance sheet riskFlag

Sector Peer Comparison(Healthcare โ€” Rank #230 of 344 stocks)

StockScoreP/ERev GrowthMarginMkt Cap
LMRI27.1N/A1.4%-9.9%$1.4B
INCY89.915.821.2%25.0%$20.2B
GMAB86.113.122.8%36.4%$18.1B
CPRX83.713.723.5%37.6%$2.9B
ASND78.316.698.0%-31.7%$14.0B
EXEL78.315.17.0%33.7%$11.9B
VRTX78.232.18.9%32.9%$125.2B
NBIX75.126.521.4%16.7%$13.3B
RPRX75.025.15.1%32.4%$19.8B
HOLX74.831.11.7%13.8%$16.8B
AMGN74.226.010.0%21.0%$210.2B
ARGX73.735.178.6%38.0%$48.0B
REGN73.019.41.0%31.4%$81.3B
ALKS72.916.5-6.4%23.9%$5.0B
ISRG72.761.720.5%28.4%$177.8B
KRYS71.541.4473.0%30.7%$8.0B
Sector Average36.641.9161.5%-3292.7%โ€”

Market Sentimentvia FMP

Analyst Consensus
Strong Buy1 analysts
Strong Buy: 1
Price Target
$23consensus
Low $22Median $23High $23
+59.6% to consensus target

Company Overviewvia FMP

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is based in Raleigh, North Carolina.

CEO
Caitlin Zulla
Beta
0.00
Industry
Medical - Devices
FMP-Identified Peers

Technical Picturecomputed from daily prices

RSI (14)
68.2
Neutral
Trend
Bearish
10-day vs 50-day MA
From 52W High
-27.3%
High: $19.45
From 52W Low
+41.8%
Low: $9.97
Moving Averages
10-Day
$14.80
Below
20-Day
$13.50
Above
50-Day
$15.20
Below
200-Day
N/A
60-Day Support
$9.97
60-Day Resistance
$19.45

Entry & Exit Zones

Avoid
No Entry
โ€”
Insufficient technical data
Exit Target
โ€”
โ€”
Stop Level
โ€”
โ€”

Not enough price history to compute reliable entry and exit zones for this stock.

Technical zones only โ€” derived from moving averages and price structure. Not financial advice. Past technical patterns do not guarantee future performance.

Financial Statementslast 4 quarters via FMP

MetricQ4 2024
Revenue$248M
Gross Profit$22M
Operating Income$15M
Net Income$-25M
EPS (Diluted)$-0.26
Gross Margin8.7%
Operating Margin6.1%
Net Margin-10.1%

Why This Stock

Healthcare

Tradability FilterGrade A โ€” 80/100Score impact: -40.9pt

Volume
90
756K avg/day
Dollar Vol
63
$11M/day
Float
98
94M shares
Mkt Cap
49
$1.4B
Range
100
95% spread
Composite Liquidity Score80/100
FDCBA

Growth Projection Adjustment

0.7x dampening
weinstein basing

Growth estimates have been dampened based on technical and fundamental signals. This is a post-hoc adjustment to prevent overly optimistic projections for stocks showing declining momentum or deteriorating fundamentals.

Free Float
99.6%
Outstanding Shares
95M
Bid-Ask Spread
95.0%
Institutional Tradable
Yes

Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.